Theraly Fibrosis, Inc.
Pharmaceutical company · Germantown, Maryland, United States
Theraly Fibrosis, Inc. is a pharmaceutical company headquartered in Germantown, Maryland, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $4.9 million sold in a notice filed in 2018.
Theraly Fibrosis at a glance
What does Theraly Fibrosis do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2017 to 2020). NIH funding came from the National Institute on Alcohol Abuse and Alcoholism.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4.9 million sold (2018).
Frequently asked questions about Theraly Fibrosis
Where is Theraly Fibrosis headquartered?
Theraly Fibrosis, Inc. is headquartered in Germantown, Maryland, United States.
What does Theraly Fibrosis do?
Theraly Fibrosis, Inc. is a pharmaceutical company.
When was Theraly Fibrosis founded?
The earliest incorporation on record for Theraly Fibrosis, Inc. is in 2015, according to public company registers.
Similar companies
- Precigen, Inc.Germantown, Maryland, United States
- Orgenesis Inc.Germantown, Maryland, United States
- Barinthus Biotherapeutics plc.Germantown, Maryland, United States
- Beacon Topco, Inc.Germantown, Maryland, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences